Table 1

Clinical and patient-reported outcomes with change from baseline to 6 months for patients with ≥80% adherence and <80% adherence

OutcomeGLP1RA+basal insulin groupBasal-bolus insulin group
Month 6 to baselineMonth 6 to baseline
≥80% adherence n=32<80% adherence n=22≥80% adherence n=20<80% adherence n=36
HbA1c (%)−4.41 (−5.23 to −3.59)−3.63 (−4.68 to −2.58)−3.61 (−4.63 to −2.59)−2.60 (−3.46 to −1.74)
Weight (kg)−1.3 (−3.2 to 0.67)0.31 (−2.2 to 2.9)4.6 (2.2 to 7.0)2.1 (0.1 to 4.0)
D-QOL
General health perception−0.94 (−1.27 to −0.60)−0.78 (−1.19 to −0.36)−0.35 (−0.77 to 0.07)−0.30 (−0.66 to 0.06)
Treatment satisfaction−0.59 (−0.86 to −0.32)−0.65 (−0.98 to −0.31)−0.25 (−0.59 to 0.08)−0.25 (−0.55 to 0.04)
Hypoglycemia fear−0.18 (−0.46 to 0.10)−0.28 (−0.62 to 0.06)0.04 (−0.32 to 0.39)0.44 (0.14 to 0.75)
  • Results are least squares mean change from baseline (95% CIs) from mixed effects linear models.

  • D-QOL, Diabetes Quality of Life Questionnaire; GLP1RA, glucagon-like peptide-1 receptor agonist.